Actively Recruiting
Perioperative Hemostasis Management in Liver Transplantation
Led by Société Française d'Anesthésie et de Réanimation · Updated on 2026-04-02
1200
Participants Needed
16
Research Sites
115 weeks
Total Duration
On this page
Sponsors
S
Société Française d'Anesthésie et de Réanimation
Lead Sponsor
L
Laboratoire français de Fractionnement et de Biotechnologies
Collaborating Sponsor
AI-Summary
What this Trial Is About
Liver transplantation (LT) is a surgery with risk of bleeding. Several risk factors have been identified: complex dissection, portal hypertension, history of ascites fluid infections, history of surgical procedures, pre-existing complex hemostatic disorders and those acquired during the procedure. Diffuse bleeding can occur at any time during the 3 phases of surgery: dissection, anhepatic and neohepatic. However, intraoperative bleeding and transfusion requirements remain difficult to predict. Current predictive models are based in particular on preoperative characteristics and do not take into account the course and different phases of the operation. The need for transfusions has largely decreased over the last 20 years, and currently around 20-25% of patients are transfused (transfusion of at least 1 blood product during LT). However, massive transfusion is necessary in 10% of LT. The European Society of Anaesthesiology (ESA) has issued recommendations on the management of severe bleeding during surgery. However, these recommendations are not specific to LT. Moreover, transfusion strategies vary widely from one center to another. The implementation of protocols within teams dedicated to LT has led to a reduction in bleeding and transfusion, with or without the use of viscoelastic testing. Intraoperative bleeding and transfusion requirements, as well as postoperative thromboembolic complications, remain difficult to predict. Predictive models of bleeding risk have been developed, but they are based solely on preoperative characteristics and do not take into account the course and various phases of the operation. In addition, new methods such as Bayesian inference or machine learning have been developed, and seem capable of providing different information from that obtained by conventional models. The overall aim of this prospective multicenter observational study is to investigate the risk factors for bleeding and thrombosis in per- and post-operative LT using different predictive methods, and to describe the management of bleeding and post-operative anticoagulation in metropolitan France.
CONDITIONS
Official Title
Perioperative Hemostasis Management in Liver Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 or over
- Liver transplant patient
You will not qualify if you...
- Multi-organ transplantation
- Protected populations: under guardianship or curatorship
- Patients not affiliated to a social security scheme
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 16 locations
1
Chru Minjoz
Besançon, France
Actively Recruiting
2
CHU Estaing
Clermont, France
Not Yet Recruiting
3
Hôpital Beaujon
Clichy, France
Not Yet Recruiting
4
CHU Grenoble Alpes
Grenoble, France
Not Yet Recruiting
5
CHU Claude Huriez
Lille, France
Actively Recruiting
6
Hôpital de la Croix-Rousse
Lyon, France
Actively Recruiting
7
CHU La Timone
Marseille, France
Not Yet Recruiting
8
Hôpital St Eloi
Montpellier, France
Not Yet Recruiting
9
Hôpital De L'Archet 2
Nice, France
Not Yet Recruiting
10
CHU Pitié-Salpêtrière
Paris, France
Not Yet Recruiting
11
CHU Haut Levêque
Pessac, France
Not Yet Recruiting
12
CHU Pontchaillou
Rennes, France
Not Yet Recruiting
13
CHU Hautepierre
Strasbourg, France
Not Yet Recruiting
14
CHU Toulouse Rangueil
Toulouse, France
Not Yet Recruiting
15
CHU Tours
Tours, France
Not Yet Recruiting
16
Hôpital Paul Brousse
Villejuif, France
Actively Recruiting
Research Team
E
Emmanuel WEISS, MD
CONTACT
S
Stéphanie ROULLET, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here